Publications

5-Flourouracil

A PROSPECTIVE, MULTI-CENTER STUDY OF INDIVIDUALIZED, PHARMACOKINETICALLY (PK)-GUIDED DOSING OF 5-FLUOROURACIL (5-FU) IN METASATIC COLORECTAL CANCER (mCRC) PATIENTS TREATED WITH WEEKLY OR BIWEEKLY 5-FU/OXALIPLATIN CONTAINING REGIMENS - CESAR 5-FU (C-II-009) ASCO 2015 Poster 34

ANALYTICAL VALIDATION STUDIES OF 5-FLOUROURACIL ASSAY; THE USE OF THE SEIMENS ADVIAR 1800 FOR PERSONALIZED MEDICINE IN ONCOLOGY -  AACC 2013 Poster

PHARMACOKINETIC (PK) GUIDED OPTIMIZATION OF 5-FLOUROURACIL (5-FU) EXPOSURE IN COLORECTAL CANCER (CRC) PATIENTS: US BASED CLINICAL PRACTICES EXPERIENCE - ASCO 2014 Poster 37

5-FU MONITORING IN CLINICAL PRACTICE: PHARMACOKINETIC VARIABILITY - ESMO 2013 Poster

5-FU ASSAY APPLICATIONS FOR THE THERMO FISHER CDx 90R AND ROCHE COBASR - AACC 2012 Poster

RAPID 5-FLOUROURACIL PLASMA QUANTIFICATION BY IMMUNOASSAY:  VALIDATION WITH FOLFOX6 CLINICAL SAMPLES - ASCO 2011 Poster

CONTROL OF PRE-ANALYTICAL VARIABLES FOR IMPROVED ACCURACY OF 5-FLOUROURACIL RESULTS - ASCO 2011 Poster

PHARMACOKINETICALLY GUIDED 5-FU MONITORING:  EXPERIENCE WITH 24H CONTINUOUS INFUSION 5-FU - CESAR 2010 Poster

5-FLUOROURACIL PLASMA DETERMINATION:  AUTOMATED IMMUNOASSAY FOR GENERAL CHEMISTRY ANALYZERS - COSA 2009 Poster

Paclitaxel

OPEN-LABEL, RANDOMIZED STUDY OF INDIVIDUALIZED, PHARMACOKINETICALLY (PK)-GUIDED DOSING OF PACLITAXEL COMBINED WITH CARBOPLATIN IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS. - CEPAC-TDM (C-III-002) ASCO 2015 Poster 374

PACLITAXEL (PTX) DOSE INDIVIDUALIZATION BY EXPOSURE OPTIMIZATION IN CHINESE PATIENTS WITH ADVANCED NON SMALL-CELL LUNG (NSCLC) RECEIVING FIRST-LINE PACLITAXEL-CARBOPLATIN (PC) CHEMOTHERAPY - SHANGHAI PULMONARY (FOS-Shangnai2-PTX) ASCO 2015 Poster 375

PACLITAXEL BLOOD MANAGEMENT:  ANALYTICAL VALIDATION OF A RAPID AUTOMATED IMMUNOASSAY - ISOBM 2012 Poster

Imatinib

PROOF OF CONCEPT:  A PROTOTYPE ASSAY FOR HIGH SPEED IMATINIB QUANTITATION BY IMMUNOASSAY - IATDMCT 2013 Poster

Docetaxel

DOCETAXEL BLOOD MANAGEMENT:  ANALYTICAL VALIDATION OF A RAPID AUTOMATED IMMUNOASSAY - COSA 2012 Poster

Aβ42

BIOMARKER STABILITY CSF:  PRE-ANALYTICAL FACTORS IN PROSPECTIVE COLLECTION - AAIC 2014 Poster

STABILITY PERFORMANCE OF FULLY AUTOMATED CHEMILUMINESCENT Aβ42 ASSAY OVER A 54-WEEK STUDY - AAIC 2013 Poster

PERFORMANCE TESTING OF FULLY AUTOMATED CHEMILUMINESCENT Aβ42 ASSAY - AAIC 2013 Poster

REPRODUCIBILITY OF A FULLY AUTOMATED CHEMILUMINESCENT Aβ42 ASSAY WITH CONTROL FLUIDS AND CEREBROSPINAL FLUID - AAIC 2013 Poster

Tau Protein

PERFORMANCE TESTING OF FULLY AUTOMATED CHEMILUMINESCENT TAU ASSAY - AAIC 2013 Poster

REPRODUCIBILITY OF A FULLY AUTOMATED CHEMILUMINESCENT TAU ASSAY - AAIC 2013 Poster

STABILITY PERFORMANCE OF A FULLY AUTOMATED CHEMILUMINESCENT TAU ASSAY WITH CEREBROSPINAL FLUID OVER A 30 WEEK STUDY - AAIC 2013 Poster

Aβ42 and Tau

ANALYTICAL PERFORMANCE TESTING OF CHEMILUMINESCENT SYSTEM ASSAYS FOR Aβ42 PEPTIDE AND TAU PROTEIN - AACC 2013 Poster

INITIAL EVALUATION OF FULLY AUTOMATED CHEMILUMINESCENT Aβ42 AND TAU ASSAYS - AAIC 2013 Poster

DETERMINATION OF AMYLOID-β1-42 AND TAU BIOMARKERS IN CEREBROSPINAL FLUID USING THE ENHANCED CHEMILUMINESCENT TECHNOLOGY PLATFORM - AACC 2012 Poster

Busulfan

A MULTICENTER EVALUATION OF A NOVEL NANOPARTICLE ASSAY TO QUANTIFY BUSULFAN IN PLASMA - AACC 2009 Poster